June 5, 2023
BMS presents positive four-year results for Opdivo combination in lung cancer
Bristol-Myers Squibb’s CheckMate-9LA trial shows combining nivolumab, ipilimumab, and chemotherapy improves outcomes in advanced NSCLC patients.
PMGroup Worldwide Ltd